Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MAGONTEC LIMITED Capital/Financing Update 2024

Nov 11, 2024

65327_rns_2024-11-11_3c792399-dedf-4832-bb6f-3d55a710f0df.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [491 x 50] intentionally omitted <==

MAGONTEC Limited ABN 51 010 441 666

Registered office Suite 2.01, 139 Macquarie Street Sydney NSW 2000 T: +612 8084 7813

12 November 2024

Company Announcements Office Australian Securities Exchange Limited 20 Bridge Street Sydney, NSW 2000

Dear Sir/Madam,

Memorandum of Settlement with QSLM

QSLM Conditions Precedent met

Agreement to buy back and cancel 22.68m MGL shares held by QSLM representing 28.48% of MGL shares on issue

On 1 November 2024, the Company announced it had entered a Memorandum of Settlement (MoS) that addressed and resolved outstanding issues between the two companies.

The MoS was conditional on approval by a meeting of creditors of Qinghai Salt Lake Magnesium Co Ltd (QSLM) and acceptance by a court in Xining, Qinghai province PRC that has oversight of QSLM’s restructuring process.

On 6 November 2024, the QSLM Creditors Meeting approved the restructuring proposal and on 11 November 2024 the Xining court approved the resolutions of the Creditors Meeting.

The Company will now seek shareholder approval to buyback and cancel shares held by QSLM in Magontec Limited at an Extraordinary General Meeting (EGM) pursuant to ASX Listing Rule 10.1.

QSLM is currently Magontec’s largest shareholder with 28.48% of the issued FPOs.

An EGM timetable will be announced as soon as practicable.

Nicholas Andrews

CEO and Executive Chairman

Dean Taylor, Company Secretary of Magontec Limited has authorised the release of this document to the market on 12 November 2024.